Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.

Tissue antigens - 1 Aug 2011

Karabon L, Jedynak A, Giebel S, Wołowiec D, Kielbinski M, Woszczyk D, Kapelko-Slowik K, Kuliczkowski K, Frydecka I

Abstract excerpt

The aim of this study was to analyze the association between gene polymorphisms of killer-cell immunoglobulin-like receptors (KIRs) and their human leukocyte antigen (HLA) ligands and susceptibility to B-cell chronic lymphocytic leukemia (B-CLL) and the clinical course of disease. The distribution of individual KIR genes in 197 B-CLL patients and 200 controls was similar, except for a tendency for lower...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to HLA Antigens

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Ligands

Share to Prevalence

Share to Receptors, KIR

Source

Identifiers

PMID: 21726204
DOI: 10.1111/j.1399-0039.2011.01721.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.PMID 21726204Read ↗

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.Semantic proximity Read ↗

Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.Semantic proximity Read ↗

Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.Semantic proximity Read ↗

Activating KIR3DS1: A key driver of KIR3DL1/HLA-Bw4-linked risk in CML.Semantic proximity Read ↗

Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.Semantic proximity Read ↗

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.Semantic proximity Read ↗

Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.Semantic proximity Read ↗

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association StudySemantic proximity Read ↗

Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.Semantic proximity Read ↗

Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.Semantic proximity Read ↗

Exploration of KIR genes and hematological-related diseases in Chinese Han population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.